tm logo
Trademark Search
ZILQIVIK

View On IC.GC.CA

ZILQIVIK
ADVERTISED

on 23 Oct 2024

Last Applicant/ Owned by

UCB BIOPHARMA SRL

Allée de la Recherche 60B-1070 Brussels,

BE

Serial Number

2160303 filed on 14th Jan 2022

Correspondent Address

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

CA

H3B1S6

ZILQIVIK

Trademark usage description

pharmaceutical preparations and substances for the treatment of immunology diseases and disorders and neurology diseases and disorders, namely myasthe Read More

Classification Information

Class [005]
Pharmaceutical preparations and substances for the treatment of immunology diseases and disorders and neurology diseases and disorders, namely myasthenia gravis, Alzheimer's, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury and seizure disorders, diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies, diseases and disorders of the central nervous system namely brain, movement, ocular motility and spinal cord diseases.

Classification kind code

11

Mark Details

Serial Number

2160303

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 42
on 23rd Oct 2024		Advertised
Submitted for opposition 26
on 27th Sep 2024		Approved
Submitted for opposition 27
on 27th Sep 2024		Approval Notice Sent
Submitted for opposition 22
on 19th Jan 2024		Search Recorded
Submitted for opposition 20
on 19th Jan 2024		Examiner's First Report
Submitted for opposition 67
on 15th Dec 2023		Agent Name Changed
Submitted for opposition 287
on 13th Jul 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 14th Jan 2022		Filed
Submitted for opposition 1
on 14th Jan 2022		Created
Submitted for opposition 31
on 14th Jan 2022		Formalized